mylan

EpiPen Price Hike Costs The Pentagon Millions

EpiPen Price Hike Costs The Pentagon Millions

The stock price of Mylan is soaring, but the pharmaceutical company might not be out of the woods yet. After a winter of bad headlines, Congressional testimony and agreements to pay back millions to the US government, the Pentagon is looking at how much Mylan has been overcharging since 2008.